IOBT (IOBT)
IO Biotech, Inc.
NASDAQ:IOBTHealthcare · Biotechnology
Mkt Cap-
Float13.91M
O/S-
Inst Own-
Dilution
Delisting Issues Timeline
Financials Summary
Revenue$0
Net Income-$95.49M
Total Assets$67.7M
Free Cash Flow-$82.39M
Debt & Equity
Debt 4%
Equity 96%
Total Debt$1.92M
Total Equity$47.02M
Shares Outstanding
Short Interest
Split History
No splits on record
Nothing in IOBT's public trading history: no forward or reverse split has affected the share count.
Balance Sheet Details
Assets$67.7M
Liabilities$20.68M
Accounts Receivable$1.13M
Accounts Payable$4.66M
Inventory$0
PP&E (Net)$2.36M
Goodwill$0
Intangible Assets$0
Income Statement
| Period | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD |
| Period Ending | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | - | - | - | - | - | - |
| Cost of Revenue | $849K | $756K | $540K | $0 | $0 | $0 |
| Gross Profit | -$849K | -$756K | -$540K | $0 | $0 | $0 |
| Gross Margin | - | - | - | - | - | - |
| Research and Development | $71.48M | $67.83M | $46.99M | $30.15M | $8.46M | $7.94M |
| Selling, General, and Administrative | $22.84M | $22.86M | $23.9M | $11.08M | $1.68M | $1.98M |
| Other | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Operating Expenses | $94.33M | $90.69M | $70.88M | $41.23M | $10.14M | $9.91M |
| Operating Income (EBIT) | -$95.18M | -$91.44M | -$71.42M | -$41.23M | -$10.14M | -$9.91M |
| Operating Margin | - | - | - | - | - | - |
| Interest Expense | $0 | $0 | $302K | $361K | $26K | $6K |
| Interest Income | $4.72M | $5.88M | $1.41M | $361 | $26 | $6 |
| Other Income (Expense) | $1.13M | $6.21M | $1.24M | -$26.58M | -$1.9M | -$830K |
| Income Before Tax (EBT) | -$94.05M | -$85.23M | -$70.19M | -$67.81M | -$12.04M | -$10.74M |
| Income Tax Expense | $1.44M | $852K | $1.27M | $68K | $0 | $0 |
| Net Income | -$95.49M | -$86.08M | -$71.46M | -$67.88M | -$12.04M | -$10.75M |
| Net Income Margin | - | - | - | - | - | - |
| Supplementary Data | ||||||
| EPS | -1.45 | -1.98 | -2.48 | -2.36 | -1.05 | -60.73 |
| Diluted EPS | -1.45 | -1.98 | -2.48 | -2.36 | -1.05 | -60.66 |
| Weighted Average OS | 65.88M | 43.54M | 28.82M | 28.82M | 11.55M | 177,000 |
| EBITDA | -$93.2M | -$84.47M | -$69.34M | -$67.45M | -$12.02M | -$824K |
| EBITDA Margin | - | - | - | - | - | - |
Balance Sheet
| Period | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD |
| Period Ending | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Assets | ||||||
| Current Assets | ||||||
| Cash and Cash Equivalents | $60.03M | $143.19M | $142.59M | $211.53M | $3.4M | $7.85M |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 |
| Cash and Short-Term Investments | $60.03M | $143.19M | $142.59M | $211.53M | $3.4M | $7.85M |
| Accounts Receivable | $1.13M | $1.13M | $1.53M | $2.09M | $1.5M | $1.23M |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $803K | $754K | $685K | $149K | $371K | $103K |
| Total Current Assets | $64.95M | $147.25M | $148.22M | $221.74M | $5.63M | $9.4M |
| Long-Term Assets | ||||||
| Property, Plant & Equipment Net | $2.36M | $3.11M | $3.23M | $155K | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $268K | $268K | $268K | $268K | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $117K | $357K | $84K | $127K | $18K | $20K |
| Total Long-Term Assets | $2.75M | $3.46M | $3.59M | $550K | $18K | $20K |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $67.7M | $150.72M | $151.81M | $222.29M | $5.65M | $9.42M |
| Liabilities | ||||||
| Current Liabilities | ||||||
| Accounts Payable | $4.66M | $3.88M | $4M | $3.93M | $522K | $997K |
| Short-Term Debt | $0 | $0 | $515K | $0 | $0 | $8.66M |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $500K | $5.03M | $4.29M | $461K | $1.74M | $931K |
| Total Current Liabilities | $19.49M | $15.72M | $10.68M | $10.3M | $3.05M | $10.84M |
| Long-Term Liabilities | ||||||
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $0 | $0 | $0 | $59K | $0 | $52K |
| Total Long-Term Liabilities | $1.2M | $1.84M | $2.27M | $59K | $0 | $52K |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $20.68M | $17.56M | $12.95M | $10.36M | $3.05M | $10.89M |
| Stockholders' Equity | ||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $37.91M | $22.06M |
| Common Stock | $66K | $66K | $29K | $29K | $8K | $28K |
| Retained Earnings | -$359.31M | -$263.82M | -$177.74M | -$106.28M | -$38.4M | -$26.36M |
| Comprehensive Income & Other | -$6.85M | -$9.67M | -$10.14M | -$1.49M | $1.96M | $1.3M |
| Other Stockholders' Equity | $406.26M | $396.92M | $316.56M | $318.18M | $41M | $24.86M |
| Total Equity | $47.02M | $133.16M | $138.85M | $211.92M | $2.6M | -$1.47M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $67.7M | $150.72M | $151.81M | $222.29M | $5.65M | $9.42M |
| Supplementary Data | ||||||
| Total Debt | $1.92M | $2.49M | $2.79M | $0 | $0 | $8.66M |
| Net Debt | -$58.12M | -$140.7M | -$139.8M | -$211.53M | -$3.4M | $817K |
Cash Flow Statement
| Period | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD |
| Period Ending | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Operating Activities | ||||||
| Net Income | -$95.49M | -$86.08M | -$71.46M | -$67.88M | -$12.04M | -$10.74M |
| Depreciation & Amortization | $849K | $756K | $540K | $2K | $0 | $9.91M |
| Deferred Income Tax | $0 | $0 | $87K | -$2K | $0 | $0 |
| Stock-Based Compensation | $6.53M | $8.06M | $7.04M | $1.79M | $64K | $131K |
| Changes in Working Capital: | ||||||
| Accounts Receivable | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 |
| Accounts Payable | $782K | -$126K | $77K | $3.41M | -$475K | $103K |
| Other Working Capital | $1.4M | $5.99M | $4.12M | -$4.18M | $623K | $790K |
| Total Working Capital Change | $2.18M | $5.86M | $4.19M | -$776K | $148K | $893K |
| Other Non-Cash Items | $3.59M | -$331K | -$130K | $26.22M | $1.87M | -$9.09M |
| Net Cash from Operating | -$82.35M | -$71.74M | -$59.73M | -$40.65M | -$9.96M | -$8.89M |
| Investing Activities | ||||||
| Capital Expenditures | -$44K | -$323K | -$690K | -$153K | $0 | $0 |
| Acquisitions | $0 | $0 | $0 | $0 | $0 | $0 |
| Purchases of Investments | $0 | $0 | $0 | $0 | $0 | $0 |
| Sales of Investments | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Investing Activities | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Cash from Investing | -$44K | -$323K | -$690K | -$153K | $0 | $0 |
| Financing Activities | ||||||
| Debt Repaid | - | - | - | - | - | -$9.01M |
| Common Stock Issuance | $0 | $75.06M | $0 | $115.11M | $0 | $0 |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $0 | -$3.2M | $0 | -$12.11M | -$14K | $0 |
| Net Cash from Financing | $0 | $71.86M | $0 | $252.95M | $5.1M | $9.01M |
| Forex Effect | -$771K | $803K | -$8.52M | -$3.76M | $413K | -$248K |
| Net Change in Cash | -$83.16M | $603K | -$68.94M | $208.39M | -$4.44M | -$125K |
| Supplementary Data | ||||||
| Operating Cash Flow | -$82.35M | -$71.74M | -$59.73M | -$40.65M | -$9.96M | -$8.89M |
| Capital Expenditure | -$44K | -$323K | -$690K | -$153K | $0 | $0 |
| Free Cash Flow | -$82.39M | -$72.06M | -$60.42M | -$40.8M | -$9.96M | -$8.89M |
| Cash at Beginning | $143.46M | $142.86M | $211.8M | $3.4M | $7.85M | $7.97M |
| Cash at End | $60.3M | $143.46M | $142.86M | $211.8M | $3.4M | $7.85M |